Suppr超能文献

一家三级综合医院过去十年中80岁及以上患者致密性玻璃体积血的病因及视力预后

Etiological Factors and Visual Outcomes of Dense Vitreous Hemorrhage in Patients Aged 80 years and above over the Past Decade in a Tertiary General Hospital.

作者信息

Ding Yuhua, Yao Bangtao, Ye Hui, Wang Fei

机构信息

Department of Ophthalmology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

Department of Ophthalmology, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, Jiangsu, China.

出版信息

J Ophthalmol. 2023 Sep 28;2023:8851207. doi: 10.1155/2023/8851207. eCollection 2023.

Abstract

This study aimed to investigate the main etiological factors and visual outcomes in patients with dense vitreous hemorrhage (DVH) aged ≥80 years. We retrospectively included patients with DVH aged ≥80 years who were admitted to our ophthalmology department between January 1, 2010, and December 31, 2019. All patients underwent pars plana vitrectomy (PPV). Data regarding demographic characteristics; preoperative and postoperative best-corrected visual acuity (BCVA), intraocular pressure (IOP), and ophthalmic B-scan ultrasonography findings; intraoperative conditions; and postoperative complications were collected and analyzed. A total of 44 patients (44 eyes) were enrolled, with a median age of 82 years; among them, 25 patients (56.82%) were men. The median preoperative BCVA was 2.3 (1.1-3.0). The main etiological factors included retinal vein occlusion (RVO) (20 eyes, 45.45%), polypoidal choroidal vasculopathy (PCV) (15 eyes, 34.09%), proliferative diabetic retinopathy (PDR) (7 eyes, 15.90%), retinal arterial macroaneurysm (RAM) (1 eye, 2.27%), and posterior vitreous detachment (PVD) (1 eye, 2.27%). The median final BCVA was 1.92 (0.5-2.6). There was a significant postoperative improvement in the BCVA; moreover, branch RVO (BRVO) had a better postoperative visual prognosis than central RVO (CRVO), PCV, and PDR ( < 0.05). The final postoperative BCVA was significantly better when the initial BCVA was above hand motion (HM) than when it was HM or lower ( < 0.05). Our findings indicate that RVO, PCV, and PDR were the main causes of DVH. Microinvasive PPV is a safe and effective method that can clarify diagnosis and improve BCVA. Patients with BRVO and preoperative BCVA > HM may have a relatively good visual prognosis. For patients aged ≥80 years who have an appropriate general condition, PPV can be timely performed to treat DVH.

摘要

本研究旨在调查年龄≥80岁的致密性玻璃体出血(DVH)患者的主要病因及视力预后。我们回顾性纳入了2010年1月1日至2019年12月31日期间在我院眼科住院的年龄≥80岁的DVH患者。所有患者均接受了玻璃体切割术(PPV)。收集并分析了患者的人口统计学特征、术前和术后最佳矫正视力(BCVA)、眼压(IOP)、眼科B超检查结果、术中情况及术后并发症等数据。共纳入44例患者(44只眼),中位年龄为82岁;其中男性25例(56.82%)。术前BCVA中位数为2.3(1.1 - 3.0)。主要病因包括视网膜静脉阻塞(RVO)(20只眼,45.45%)、息肉样脉络膜血管病变(PCV)(15只眼,34.09%)、增殖性糖尿病视网膜病变(PDR)(7只眼,15.90%)、视网膜动脉大动脉瘤(RAM)(1只眼,2.27%)和玻璃体后脱离(PVD)(1只眼,2.27%)。最终BCVA中位数为1.92(0.5 - 2.6)。术后BCVA有显著改善;此外,分支RVO(BRVO)的术后视力预后优于中央RVO(CRVO)、PCV和PDR(P < 0.05)。初始BCVA高于手动(HM)时的最终术后BCVA明显优于初始BCVA为HM或更低时(P < 0.05)。我们的研究结果表明,RVO、PCV和PDR是DVH的主要原因。微创PPV是一种安全有效的方法,可明确诊断并改善BCVA。BRVO且术前BCVA > HM的患者可能有相对较好的视力预后。对于年龄≥80岁且全身状况适宜的患者,可及时进行PPV治疗DVH。

相似文献

本文引用的文献

8
Retinopathy in diabetes.糖尿病性视网膜病变
Diabetes Care. 2004 Jan;27 Suppl 1:S84-7. doi: 10.2337/diacare.27.2007.s84.
10
Muscle strength before and mortality after a bone fracture in older people.
Scand J Med Sci Sports. 2002 Oct;12(5):296-300. doi: 10.1034/j.1600-0838.2002.102100.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验